NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 88 filers reported holding NATERA INC in Q3 2017. The put-call ratio across all filers is 0.10 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $569,893,884 | -4.8% | 5,262,664 | -19.6% | 2.77% | -6.7% |
Q1 2024 | $598,781,944 | +35.1% | 6,546,927 | -7.5% | 2.97% | +24.1% |
Q4 2023 | $443,281,419 | +44.0% | 7,076,651 | +1.7% | 2.39% | +35.2% |
Q3 2023 | $307,811,231 | -13.7% | 6,956,186 | -5.0% | 1.77% | -2.9% |
Q2 2023 | $356,470,509 | -17.9% | 7,325,740 | -6.3% | 1.82% | -21.6% |
Q1 2023 | $434,106,716 | +20.4% | 7,818,925 | -12.9% | 2.32% | +18.8% |
Q4 2022 | $360,438,299 | -6.3% | 8,972,823 | +2.2% | 1.95% | +0.2% |
Q3 2022 | $384,799,000 | +49.8% | 8,781,346 | +21.2% | 1.95% | +62.6% |
Q2 2022 | $256,846,000 | -2.0% | 7,247,345 | +12.4% | 1.20% | +43.1% |
Q1 2022 | $262,220,000 | -58.7% | 6,445,905 | -5.3% | 0.84% | -47.4% |
Q4 2021 | $635,521,000 | -17.8% | 6,805,028 | -1.9% | 1.59% | -13.7% |
Q3 2021 | $773,266,000 | +8.7% | 6,938,855 | +10.8% | 1.84% | +9.9% |
Q2 2021 | $711,106,000 | +21.2% | 6,263,598 | +8.4% | 1.68% | +9.3% |
Q1 2021 | $586,704,000 | -5.2% | 5,778,060 | -7.1% | 1.54% | -4.7% |
Q4 2020 | $618,784,000 | +54.1% | 6,217,680 | +11.9% | 1.61% | +38.1% |
Q3 2020 | $401,531,000 | +123.3% | 5,558,291 | +54.1% | 1.17% | +97.0% |
Q2 2020 | $179,785,000 | -8.8% | 3,605,801 | -45.4% | 0.59% | +36.7% |
Q1 2020 | $197,110,000 | +57.7% | 6,601,116 | +77.9% | 0.43% | -5.9% |
Q4 2019 | $125,024,000 | +2.2% | 3,710,998 | -0.5% | 0.46% | -4.2% |
Q3 2019 | $122,343,000 | +22.0% | 3,729,973 | +2.5% | 0.48% | +24.7% |
Q2 2019 | $100,317,000 | +14.9% | 3,637,319 | -14.1% | 0.38% | +10.6% |
Q1 2019 | $87,274,000 | +114.7% | 4,232,500 | +45.3% | 0.35% | +86.1% |
Q4 2018 | $40,656,000 | -25.4% | 2,912,312 | +27.9% | 0.19% | -8.8% |
Q3 2018 | $54,508,000 | +63.8% | 2,276,850 | +28.8% | 0.20% | +46.4% |
Q2 2018 | $33,271,000 | +15092.2% | 1,767,833 | +10299.0% | 0.14% | +13900.0% |
Q3 2017 | $219,000 | -46.6% | 17,000 | -55.0% | 0.00% | -50.0% |
Q3 2015 | $410,000 | – | 37,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 503,094 | $54,480,049 | 52.98% |
Kynam Capital Management, LP | 2,014,408 | $218,140,242 | 16.83% |
Eagle Health Investments LP | 474,114 | $51,341,805 | 9.00% |
Sofinnova Investments, Inc. | 1,550,280 | $167,879,821 | 8.72% |
Eversept Partners, LP | 1,173,494 | $127,077,665 | 8.70% |
Lagoda Investment Management, L.P. | 130,195 | $14,098,817 | 8.11% |
Duquesne Family Office | 1,974,880 | $213,860 | 7.33% |
Tri Locum Partners LP | 230,585 | $24,970,050 | 6.31% |
PERKINS CAPITAL MANAGEMENT INC | 57,550 | $6,232 | 5.87% |
PURA VIDA INVESTMENTS, LLC | 67,500 | $7,309,575 | 4.63% |